AI Generated Image
FDA approves Takeda’s narcolepsy drug, a boon for new class of treatments
statnews.com • • business
Key Points:
- The FDA approved Orzeyful, a novel twice-daily pill developed by Takeda, as a treatment for narcolepsy type 1.
- Orzeyful is an orexin receptor agonist designed to address the deficiency of orexin neurons in patients with narcolepsy.
- This drug class represents a promising advancement in sleep disorder treatments and may have potential applications for various neurological conditions.
